Mobile Trading

KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD

NSE : KIMSBSE : 543308ISIN CODE : INE967H01025Industry : Hospital & Healthcare ServicesHouse : Private
BSE633.85-14.05 (-2.17 %)
PREV CLOSE ( ) 647.90
OPEN PRICE ( ) 661.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 25299
TODAY'S LOW / HIGH ( )630.00 661.50
52 WK LOW / HIGH ( )404.12 707.5
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 26-07 1973
Management Info
Bhaskara Rao Bollineni - Chairman Bhaskara Rao Bollineni - Managing Director
Registered Office

Address D. No.1-8-31/1,Minister's Road, ,
Secunderabad,
Telangana-500003

Phone 040-44186000 / 44850000 / 44885184

Email cs@kimshospitals.com

Website www.kimshospitals.com

Registrars Details
MUFG Intime India Pvt Ltd.
Coimbatore Branch Surya , 35 Mayflower Avenue,Behind Senthil Nagar,Sowripalayam Road,Coimbatore
Listing : BSE, NSE
NEWS
21Jun Krishna Institute of Medical Sciences
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
21Jun Krishna Institute of Medical Sciences
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
18Jun Krishna Institute of Medical Sciences
Krishna Institute of Medical Sciences has informed that the details of t..
05Mar Krishna Institute of Medical Sciences
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
20Feb Krishna Institute of Medical Sciences
Krishna Institute of Medical Sciences has informed that Krishna Institut..
Financials
in Millions
QTR Mar 25 ANNUAL 25
Net Profit9353029
Gross Profit 1205 4031
Operating Profit 13304732
Net Sales 345913841
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Apollo Hospital Ent. (BSE)
up  7060.80 (0.75%)
M.Cap ( in Cr)101523.47
Max Healthcare Inst (BSE)
up  1213.55 (4.45%)
M.Cap ( in Cr)117974.88
Dr Agarwals Eye Hsp (BSE)
up  4312.40 (1.09%)
M.Cap ( in Cr)2026.83
Metropolis Health. (BSE)
up  1720.35 (2.01%)
M.Cap ( in Cr)8911.74
Dr. Lal Pathlabs (BSE)
up  2908.85 (1.15%)
M.Cap ( in Cr)24369.04
Shareholding Pattern
FI/BANKS/INSURANCE 6.2%
PROMOTERS 38.82%
MUTUAL FUNDS/UTI 25.35%
NON-INSTITUTION 13.78%
GOVERNMENT 0%
FII 0%

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.